• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022

    12/14/22 10:01:40 AM ET
    $ABCM
    $ACRS
    $ADM
    $AGRO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABCM alert in real time by email

    Upgrades

    Wolfe Research upgraded the previous rating for EQT Corp (NYSE:EQT) from Peer Perform to Outperform. EQT earned $1.04 in the third quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.97 and a 52-week-low of $19.20. EQT closed at $37.11 at the end of the last trading period.

    For Lennar Corp (NYSE:LEN), Barclays upgraded the previous rating of Equal-Weight to Overweight. At the moment, the stock has a 52-week-high of $117.54 and a 52-week-low of $62.54. Lennar closed at $90.59 at the end of the last trading period.

    According to Barclays, the prior rating for PulteGroup Inc (NYSE:PHM) was changed from Equal-Weight to Overweight. For the third quarter, PulteGroup had an EPS of $2.69, compared to year-ago quarter EPS of $1.82. The stock has a 52-week-high of $58.09 and a 52-week-low of $35.03. At the end of the last trading period, PulteGroup closed at $45.79.

    For SolarEdge Technologies Inc (NASDAQ:SEDG), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, SolarEdge Technologies showed an EPS of $0.91, compared to $1.45 from the year-ago quarter. The stock has a 52-week-high of $375.90 and a 52-week-low of $190.15. At the end of the last trading period, SolarEdge Technologies closed at $327.64.

    For RingCentral Inc (NYSE:RNG), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, RingCentral showed an EPS of $0.55, compared to $0.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $198.79 and a 52-week-low of $28.00. RingCentral closed at $38.95 at the end of the last trading period.

    Morgan Stanley upgraded the previous rating for PACCAR Inc (NASDAQ:PCAR) from Equal-Weight to Overweight. In the third quarter, PACCAR showed an EPS of $2.21, compared to $1.08 from the year-ago quarter. The current stock performance of PACCAR shows a 52-week-high of $107.18 and a 52-week-low of $77.00. Moreover, at the end of the last trading period, the closing price was at $102.22.

    For Datadog Inc (NASDAQ:DDOG), Oppenheimer upgraded the previous rating of Perform to Outperform. For the third quarter, Datadog had an EPS of $0.23, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $186.28 and a 52-week-low of $66.45. Datadog closed at $79.71 at the end of the last trading period.

    Wells Fargo upgraded the previous rating for Fortis Inc (NYSE:FTS) from Underweight to Equal-Weight. For the third quarter, Fortis had an EPS of $0.54, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $51.66 and a 52-week-low of $34.76. At the end of the last trading period, Fortis closed at $40.99.

    For Playa Hotels & Resorts NV (NASDAQ:PLYA), Citigroup upgraded the previous rating of Neutral to Buy. In the third quarter, Playa Hotels & Resorts showed an EPS of $0.04, compared to $0.09 from the year-ago quarter. The current stock performance of Playa Hotels & Resorts shows a 52-week-high of $9.81 and a 52-week-low of $5.34. Moreover, at the end of the last trading period, the closing price was at $6.12.

    According to Wedbush, the prior rating for Darden Restaurants Inc (NYSE:DRI) was changed from Neutral to Outperform. In the first quarter, Darden Restaurants showed an EPS of $1.56, compared to $1.76 from the year-ago quarter. The current stock performance of Darden Restaurants shows a 52-week-high of $155.25 and a 52-week-low of $110.96. Moreover, at the end of the last trading period, the closing price was at $145.03.

    For Gentex Corp (NASDAQ:GNTX), Goldman Sachs upgraded the previous rating of Sell to Neutral. Gentex earned $0.31 in the third quarter, compared to $0.32 in the year-ago quarter. The stock has a 52-week-high of $36.65 and a 52-week-low of $23.28. At the end of the last trading period, Gentex closed at $27.43.

    For Ncino Inc (NASDAQ:NCNO), Baird upgraded the previous rating of Neutral to Outperform. For the third quarter, Ncino had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $58.71 and a 52-week-low of $22.97. At the end of the last trading period, Ncino closed at $26.67.

    Baird upgraded the previous rating for Ansys Inc (NASDAQ:ANSS) from Neutral to Outperform. Ansys earned $1.77 in the third quarter, compared to $1.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $413.22 and a 52-week-low of $194.23. Ansys closed at $254.54 at the end of the last trading period.

    Keybanc upgraded the previous rating for EastGroup Properties Inc (NYSE:EGP) from Sector Weight to Overweight. In the third quarter, EastGroup Props showed an EPS of $1.77, compared to $1.55 from the year-ago quarter. At the moment, the stock has a 52-week-high of $229.84 and a 52-week-low of $137.47. EastGroup Props closed at $156.84 at the end of the last trading period.

    Keybanc upgraded the previous rating for Physicians Realty Trust (NYSE:DOC) from Sector Weight to Overweight. In the third quarter, Physicians Realty Trust showed an EPS of $0.26, compared to $0.26 from the year-ago quarter. The current stock performance of Physicians Realty Trust shows a 52-week-high of $19.12 and a 52-week-low of $13.42. Moreover, at the end of the last trading period, the closing price was at $15.00.

    See all analyst ratings upgrades.

    Downgrades

    According to Chardan Capital, the prior rating for Moderna Inc (NASDAQ:MRNA) was changed from Buy to Neutral. For the third quarter, Moderna had an EPS of $2.53, compared to year-ago quarter EPS of $7.70. The current stock performance of Moderna shows a 52-week-high of $321.31 and a 52-week-low of $115.03. Moreover, at the end of the last trading period, the closing price was at $197.54.

    According to Citigroup, the prior rating for Grupo Aeroportuario del Centro Norte SAB de CV (NASDAQ:OMAB) was changed from Neutral to Sell. In the third quarter, Central North Airport Gr showed an EPS of $1.13, compared to $0.81 from the year-ago quarter. The current stock performance of Central North Airport Gr shows a 52-week-high of $71.86 and a 52-week-low of $46.53. Moreover, at the end of the last trading period, the closing price was at $66.26.

    B of A Securities downgraded the previous rating for PENN Entertainment Inc (NASDAQ:PENN) from Buy to Neutral. In the third quarter, PENN Entertainment showed an EPS of $0.72, compared to $0.52 from the year-ago quarter. The stock has a 52-week-high of $53.36 and a 52-week-low of $25.49. At the end of the last trading period, PENN Entertainment closed at $35.04.

    For Stock Yards Bancorp Inc (NASDAQ:SYBT), Piper Sandler downgraded the previous rating of Neutral to Underweight. Stock Yards Bancorp earned $0.89 in the third quarter, compared to $0.87 in the year-ago quarter. The current stock performance of Stock Yards Bancorp shows a 52-week-high of $78.71 and a 52-week-low of $50.83. Moreover, at the end of the last trading period, the closing price was at $72.22.

    Barclays downgraded the previous rating for Skyline Champion Corp (NYSE:SKY) from Overweight to Equal-Weight. In the second quarter, Skyline Champion showed an EPS of $2.51, compared to $0.89 from the year-ago quarter. The current stock performance of Skyline Champion shows a 52-week-high of $83.49 and a 52-week-low of $43.04. Moreover, at the end of the last trading period, the closing price was at $55.72.

    Citigroup downgraded the previous rating for SL Green Realty Corp (NYSE:SLG) from Neutral to Sell. For the third quarter, SL Green Realty had an EPS of $1.66, compared to year-ago quarter EPS of $1.78. At the moment, the stock has a 52-week-high of $83.96 and a 52-week-low of $34.21. SL Green Realty closed at $36.35 at the end of the last trading period.

    For Coupa Software Inc (NASDAQ:COUP), Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Coupa Software had an EPS of $0.15, compared to year-ago quarter EPS of $0.31. The current stock performance of Coupa Software shows a 52-week-high of $166.21 and a 52-week-low of $40.30. Moreover, at the end of the last trading period, the closing price was at $78.60.

    For Caesars Entertainment Inc (NASDAQ:CZR), B of A Securities downgraded the previous rating of Buy to Neutral. In the third quarter, Caesars Entertainment showed an EPS of $0.24, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $97.39 and a 52-week-low of $31.31. At the end of the last trading period, Caesars Entertainment closed at $52.55.

    For Best Buy Co Inc (NYSE:BBY), B of A Securities downgraded the previous rating of Neutral to Underperform. Best Buy Co earned $1.38 in the third quarter, compared to $2.08 in the year-ago quarter. The current stock performance of Best Buy Co shows a 52-week-high of $112.96 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $84.07.

    B of A Securities downgraded the previous rating for AutoZone Inc (NYSE:AZO) from Neutral to Underperform. In the first quarter, AutoZone showed an EPS of $27.45, compared to $25.69 from the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of $2610.05 and a 52-week-low of $1703.32. Moreover, at the end of the last trading period, the closing price was at $2393.46.

    According to Daiwa Capital, the prior rating for XPeng Inc (NYSE:XPEV) was changed from Buy to Sell. XPeng earned $0.36 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.50 and a 52-week-low of $6.18. XPeng closed at $10.31 at the end of the last trading period.

    For Centerspace (NYSE:CSR), Janney Montgomery Scott downgraded the previous rating of Buy to Neutral. In the third quarter, Centerspace showed an EPS of $1.15, compared to $0.98 from the year-ago quarter. At the moment, the stock has a 52-week-high of $112.27 and a 52-week-low of $60.52. Centerspace closed at $66.15 at the end of the last trading period.

    Janney Montgomery Scott downgraded the previous rating for Essex Property Trust Inc (NYSE:ESS) from Buy to Neutral. In the third quarter, Essex Property Trust showed an EPS of $3.69, compared to $3.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $363.36 and a 52-week-low of $205.76. Essex Property Trust closed at $223.21 at the end of the last trading period.

    According to Truist Securities, the prior rating for Harpoon Therapeutics Inc (NASDAQ:HARP) was changed from Buy to Hold. In the third quarter, Harpoon Therapeutics showed an EPS of $0.35, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $8.20 and a 52-week-low of $0.66. At the end of the last trading period, Harpoon Therapeutics closed at $0.89.

    For Vornado Realty Trust (NYSE:VNO), Citigroup downgraded the previous rating of Neutral to Sell. Vornado Realty earned $0.81 in the third quarter, compared to $0.71 in the year-ago quarter. The stock has a 52-week-high of $47.26 and a 52-week-low of $20.03. At the end of the last trading period, Vornado Realty closed at $23.06.

    According to Citigroup, the prior rating for Acadia Realty Trust (NYSE:AKR) was changed from Buy to Neutral. Acadia Realty Trust earned $0.28 in the third quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.64 and a 52-week-low of $12.28. Acadia Realty Trust closed at $14.98 at the end of the last trading period.

    For Latham Group Inc (NASDAQ:SWIM), Barclays downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, Latham Group showed an EPS of $0.10, compared to $0.10 from the year-ago quarter. The stock has a 52-week-high of $27.25 and a 52-week-low of $2.75. At the end of the last trading period, Latham Group closed at $3.16.

    Morgan Stanley downgraded the previous rating for Martin Marietta Materials Inc (NYSE:MLM) from Overweight to Equal-Weight. For the third quarter, Martin Marietta Materials had an EPS of $4.69, compared to year-ago quarter EPS of $4.25. The stock has a 52-week-high of $446.46 and a 52-week-low of $284.99. At the end of the last trading period, Martin Marietta Materials closed at $368.73.

    For Adecoagro SA (NYSE:AGRO), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Adecoagro earned $0.43 in the third quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Adecoagro shows a 52-week-high of $13.55 and a 52-week-low of $6.78. Moreover, at the end of the last trading period, the closing price was at $7.62.

    For Syneos Health Inc (NASDAQ:SYNH), Mizuho downgraded the previous rating of Buy to Neutral. In the third quarter, Syneos Health showed an EPS of $1.23, compared to $1.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $104.17 and a 52-week-low of $22.89. Syneos Health closed at $35.50 at the end of the last trading period.

    Wells Fargo downgraded the previous rating for Digital Realty Trust Inc (NYSE:DLR) from Overweight to Equal-Weight. Digital Realty Trust earned $1.67 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Digital Realty Trust shows a 52-week-high of $178.22 and a 52-week-low of $85.76. Moreover, at the end of the last trading period, the closing price was at $111.09.

    According to Wells Fargo, the prior rating for Lear Corp (NYSE:LEA) was changed from Overweight to Equal-Weight. Lear earned $2.33 in the third quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Lear shows a 52-week-high of $195.43 and a 52-week-low of $114.67. Moreover, at the end of the last trading period, the closing price was at $132.19.

    For Magna International Inc (NYSE:MGA), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Magna International earned $1.07 in the third quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $90.15 and a 52-week-low of $45.58. Magna International closed at $59.87 at the end of the last trading period.

    Citigroup downgraded the previous rating for Marriott International Inc (NASDAQ:MAR) from Buy to Neutral. For the third quarter, Marriott Intl had an EPS of $1.69, compared to year-ago quarter EPS of $0.99. At the moment, the stock has a 52-week-high of $195.90 and a 52-week-low of $131.01. Marriott Intl closed at $163.12 at the end of the last trading period.

    According to Citigroup, the prior rating for Healthcare Realty Trust Inc (NYSE:HR) was changed from Buy to Neutral. In the third quarter, Healthcare Realty Trust showed an EPS of $0.39, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $32.38 and a 52-week-low of $18.40. At the end of the last trading period, Healthcare Realty Trust closed at $19.74.

    For Hilton Worldwide Holdings Inc (NYSE:HLT), Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Hilton Worldwide Holdings had an EPS of $1.31, compared to year-ago quarter EPS of $0.78. The stock has a 52-week-high of $167.99 and a 52-week-low of $108.41. At the end of the last trading period, Hilton Worldwide Holdings closed at $138.11.

    For Easterly Government Properties Inc (NYSE:DEA), Citigroup downgraded the previous rating of Buy to Neutral. Easterly Government Props earned $0.32 in the third quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $23.65 and a 52-week-low of $14.79. At the end of the last trading period, Easterly Government Props closed at $15.04.

    For Brandywine Realty Trust (NYSE:BDN), Citigroup downgraded the previous rating of Neutral to Sell. Brandywine Realty Trust earned $0.36 in the third quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.88 and a 52-week-low of $5.95. Brandywine Realty Trust closed at $6.52 at the end of the last trading period.

    For Argo Blockchain PLC (NASDAQ:ARBK), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the second quarter, Argo Blockchain showed an EPS of $0.82, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $14.80 and a 52-week-low of $0.36. At the end of the last trading period, Argo Blockchain closed at $0.43.

    Goldman Sachs downgraded the previous rating for QuantumScape Corp (NYSE:QS) from Neutral to Sell. For the third quarter, QuantumScape had an EPS of $0.27, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $25.10 and a 52-week-low of $6.61. At the end of the last trading period, QuantumScape closed at $7.09.

    According to Baird, the prior rating for SPS Commerce Inc (NASDAQ:SPSC) was changed from Outperform to Neutral. For the third quarter, SPS Commerce had an EPS of $0.63, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $146.81 and a 52-week-low of $96.41. SPS Commerce closed at $137.97 at the end of the last trading period.

    For Certara Inc (NASDAQ:CERT), Baird downgraded the previous rating of Outperform to Neutral. Certara earned $0.10 in the third quarter, compared to $0.07 in the year-ago quarter. The stock has a 52-week-high of $29.99 and a 52-week-low of $10.60. At the end of the last trading period, Certara closed at $17.40.

    Jefferies downgraded the previous rating for Armstrong World Industries Inc (NYSE:AWI) from Buy to Hold. In the third quarter, Armstrong World Indus showed an EPS of $1.36, compared to $1.17 from the year-ago quarter. The stock has a 52-week-high of $117.64 and a 52-week-low of $70.50. At the end of the last trading period, Armstrong World Indus closed at $73.37.

    According to RBC Capital, the prior rating for Healthpeak Properties Inc (NYSE:PEAK) was changed from Outperform to Sector Perform. Healthpeak Properties earned $0.43 in the third quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $36.85 and a 52-week-low of $21.41. Healthpeak Properties closed at $25.63 at the end of the last trading period.

    According to Keybanc, the prior rating for VICI Properties Inc (NYSE:VICI) was changed from Overweight to Sector Weight. For the third quarter, VICI Properties had an EPS of $0.49, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $35.69 and a 52-week-low of $26.23. VICI Properties closed at $34.39 at the end of the last trading period.

    Keybanc downgraded the previous rating for Netstreit Corp (NYSE:NTST) from Overweight to Sector Weight. For the third quarter, Netstreit had an EPS of $0.30, compared to year-ago quarter EPS of $0.22. The stock has a 52-week-high of $23.86 and a 52-week-low of $17.07. At the end of the last trading period, Netstreit closed at $19.28.

    According to Keybanc, the prior rating for LTC Properties Inc (NYSE:LTC) was changed from Overweight to Sector Weight. LTC Properties earned $0.60 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $45.49 and a 52-week-low of $32.23. At the end of the last trading period, LTC Properties closed at $38.72.

    According to Keybanc, the prior rating for Essex Property Trust Inc (NYSE:ESS) was changed from Overweight to Sector Weight. In the third quarter, Essex Property Trust showed an EPS of $3.69, compared to $3.12 from the year-ago quarter. The current stock performance of Essex Property Trust shows a 52-week-high of $363.36 and a 52-week-low of $205.76. Moreover, at the end of the last trading period, the closing price was at $223.21.

    For Coupa Software Inc (NASDAQ:COUP), Keybanc downgraded the previous rating of Overweight to Sector Weight. For the third quarter, Coupa Software had an EPS of $0.15, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $166.21 and a 52-week-low of $40.30. Coupa Software closed at $78.60 at the end of the last trading period.

    According to Keybanc, the prior rating for Acadia Realty Trust (NYSE:AKR) was changed from Overweight to Sector Weight. Acadia Realty Trust earned $0.28 in the third quarter, compared to $0.27 in the year-ago quarter. The stock has a 52-week-high of $22.64 and a 52-week-low of $12.28. At the end of the last trading period, Acadia Realty Trust closed at $14.98.

    See all analyst ratings downgrades.

    Initiations

    UBS initiated coverage on Calumet Specialty Products Partners LP (NASDAQ:CLMT) with a Neutral rating. The price target for Calumet Specialty is set to $15.70. In the third quarter, Calumet Specialty showed an EPS of $0.19, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $20.50 and a 52-week-low of $8.40. At the end of the last trading period, Calumet Specialty closed at $14.02.

    UBS initiated coverage on Darling Ingredients Inc (NYSE:DAR) with a Buy rating. The price target for Darling Ingredients is set to $91.00. For the third quarter, Darling Ingredients had an EPS of $1.17, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $87.59 and a 52-week-low of $55.71. At the end of the last trading period, Darling Ingredients closed at $60.87.

    Cowen & Co. initiated coverage on The Simply Good Foods Co (NASDAQ:SMPL) with a Market Perform rating. The price target for Simply Good Foods is set to $42.00. In the fourth quarter, Simply Good Foods showed an EPS of $0.36, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $45.77 and a 52-week-low of $29.21. At the end of the last trading period, Simply Good Foods closed at $37.79.

    Deutsche Bank initiated coverage on Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) with a Buy rating. The price target for Maravai LifeSciences is set to $25.00. Maravai LifeSciences earned $0.37 in the third quarter, compared to $0.44 in the year-ago quarter. The current stock performance of Maravai LifeSciences shows a 52-week-high of $43.50 and a 52-week-low of $12.16. Moreover, at the end of the last trading period, the closing price was at $14.27.

    For Abcam PLC (NASDAQ:ABCM), Deutsche Bank initiated coverage, by setting the current rating at Hold. NoneAt the moment, the stock has a 52-week-high of $24.00 and a 52-week-low of $12.54. Abcam closed at $15.82 at the end of the last trading period.

    With a Buy rating, Canaccord Genuity initiated coverage on Olink Holding AB (NASDAQ:OLK). The price target seems to have been set at $28.00 for Olink Holding. In the third quarter, Olink Holding showed an EPS of $0.01, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $24.93 and a 52-week-low of $8.39. At the end of the last trading period, Olink Holding closed at $23.17.

    With an Outperform rating, Raymond James initiated coverage on POINT Biopharma Global Inc (NASDAQ:PNT). The price target seems to have been set at $10.00 for POINT Biopharma Global. In the third quarter, POINT Biopharma Global showed an EPS of $0.26, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $10.98 and a 52-week-low of $4.25. At the end of the last trading period, POINT Biopharma Global closed at $6.61.

    With a Buy rating, Needham initiated coverage on Revolution Medicines Inc (NASDAQ:RVMD). The price target seems to have been set at $31.00 for Revolution Medicines. In the third quarter, Revolution Medicines showed an EPS of $0.87, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $28.11 and a 52-week-low of $14.08. At the end of the last trading period, Revolution Medicines closed at $23.30.

    Cowen & Co. initiated coverage on BellRing Brands Inc (NYSE:BRBR) with an Outperform rating. The price target for BellRing Brands is set to $31.00. In the fourth quarter, BellRing Brands showed an EPS of $0.31, compared to $0.25 from the year-ago quarter. The current stock performance of BellRing Brands shows a 52-week-high of $28.95 and a 52-week-low of $20.20. Moreover, at the end of the last trading period, the closing price was at $25.12.

    Cowen & Co. initiated coverage on OneSpaWorld Holdings Ltd (NASDAQ:OSW) with an Outperform rating. The price target for OneSpaWorld Holdings is set to $13.00. In the third quarter, OneSpaWorld Holdings showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. The current stock performance of OneSpaWorld Holdings shows a 52-week-high of $10.99 and a 52-week-low of $6.80. Moreover, at the end of the last trading period, the closing price was at $10.30.

    Morgan Stanley initiated coverage on Broadridge Financial Solutions Inc (NYSE:BR) with a Equal-Weight rating. The price target for Broadridge Financial Soln is set to $160.00. In the first quarter, Broadridge Financial Soln showed an EPS of $0.84, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $185.40 and a 52-week-low of $131.35. Broadridge Financial Soln closed at $145.20 at the end of the last trading period.

    With a Buy rating, Needham initiated coverage on Day One Biopharmaceuticals Inc (NASDAQ:DAWN). The price target seems to have been set at $40.00 for Day One Biopharmaceutical. Day One Biopharmaceutical earned $0.53 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $28.35 and a 52-week-low of $5.44. At the end of the last trading period, Day One Biopharmaceutical closed at $20.10.

    Needham initiated coverage on Theseus Pharmaceuticals Inc (NASDAQ:THRX) with a Buy rating. The price target for Theseus Pharmaceuticals is set to $22.00. In the third quarter, Theseus Pharmaceuticals showed an EPS of $0.38, compared to $5.16 from the year-ago quarter. The current stock performance of Theseus Pharmaceuticals shows a 52-week-high of $15.21 and a 52-week-low of $4.01. Moreover, at the end of the last trading period, the closing price was at $5.50.

    Needham initiated coverage on Cogent Biosciences Inc (NASDAQ:COGT) with a Buy rating. The price target for Cogent Biosciences is set to $24.00. In the third quarter, Cogent Biosciences showed an EPS of $0.50, compared to $0.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.07 and a 52-week-low of $3.79. Cogent Biosciences closed at $11.95 at the end of the last trading period.

    Stifel initiated coverage on Aclaris Therapeutics Inc (NASDAQ:ACRS) with a Buy rating. The price target for Aclaris Therapeutics is set to $29.00. For the third quarter, Aclaris Therapeutics had an EPS of $0.30, compared to year-ago quarter EPS of $0.35. The stock has a 52-week-high of $18.96 and a 52-week-low of $9.26. At the end of the last trading period, Aclaris Therapeutics closed at $15.94.

    CLSA initiated coverage on Zhihu Inc (NYSE:ZH) with an Outperform rating. The price target for Zhihu is set to $1.50. For the third quarter, Zhihu had an EPS of $0.06, compared to year-ago quarter EPS of $0.07. The current stock performance of Zhihu shows a 52-week-high of $6.38 and a 52-week-low of $0.89. Moreover, at the end of the last trading period, the closing price was at $1.29.

    Goldman Sachs initiated coverage on PTC Therapeutics Inc (NASDAQ:PTCT) with a Sell rating. The price target for PTC Therapeutics is set to $35.00. In the third quarter, PTC Therapeutics showed an EPS of $1.53, compared to $1.89 from the year-ago quarter. The stock has a 52-week-high of $55.58 and a 52-week-low of $25.01. At the end of the last trading period, PTC Therapeutics closed at $40.14.

    Goldman Sachs initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ:XENE) with a Buy rating. The price target for Xenon Pharmaceuticals is set to $60.00. For the third quarter, Xenon Pharmaceuticals had an EPS of $0.57, compared to year-ago quarter EPS of $0.36. At the moment, the stock has a 52-week-high of $41.39 and a 52-week-low of $24.36. Xenon Pharmaceuticals closed at $38.07 at the end of the last trading period.

    With a Neutral rating, Citigroup initiated coverage on Solid Power Inc (NASDAQ:SLDP). The price target seems to have been set at $3.00 for Solid Power. In the third quarter, Solid Power showed an EPS of $0.07, compared to $0.08 from the year-ago quarter. The current stock performance of Solid Power shows a 52-week-high of $11.61 and a 52-week-low of $2.52. Moreover, at the end of the last trading period, the closing price was at $2.55.

    For RPM International Inc (NYSE:RPM), Keybanc initiated coverage, by setting the current rating at Sector Weight. RPM International earned $1.47 in the first quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $106.50 and a 52-week-low of $74.56. At the end of the last trading period, RPM International closed at $104.20.

    With a Buy rating, Needham initiated coverage on Blueprint Medicines Corp (NASDAQ:BPMC). The price target seems to have been set at $60.00 for Blueprint Medicines. Blueprint Medicines earned $2.23 in the third quarter, compared to $2.00 in the year-ago quarter. The current stock performance of Blueprint Medicines shows a 52-week-high of $111.78 and a 52-week-low of $40.78. Moreover, at the end of the last trading period, the closing price was at $46.60.

    For Mirati Therapeutics Inc (NASDAQ:MRTX), Needham initiated coverage, by setting the current rating at Hold. Mirati Therapeutics earned $3.09 in the third quarter, compared to $1.55 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $154.17 and a 52-week-low of $32.96. Moreover, at the end of the last trading period, the closing price was at $41.97.

    Canaccord Genuity initiated coverage on Pagaya Technologies Ltd (NASDAQ:PGY) with a Hold rating. The price target for Pagaya Technologies is set to $1.50. The stock has a 52-week-high of $34.50 and a 52-week-low of $0.63. At the end of the last trading period, Pagaya Technologies closed at $0.69.

    With a Buy rating, BTIG initiated coverage on CompoSecure Inc (NASDAQ:CMPO). The price target seems to have been set at $9.00 for CompoSecure. At the moment, the stock has a 52-week-high of $10.69 and a 52-week-low of $4.26. CompoSecure closed at $4.86 at the end of the last trading period.

    Deutsche Bank initiated coverage on Avantor Inc (NYSE:AVTR) with a Hold rating. The price target for Avantor is set to $24.00. Avantor earned $0.34 in the third quarter, compared to $0.35 in the year-ago quarter. The stock has a 52-week-high of $42.48 and a 52-week-low of $17.91. At the end of the last trading period, Avantor closed at $22.00.

    Deutsche Bank initiated coverage on Danaher Corp (NYSE:DHR) with a Buy rating. The price target for Danaher is set to $310.00. For the third quarter, Danaher had an EPS of $2.56, compared to year-ago quarter EPS of $2.39. The current stock performance of Danaher shows a 52-week-high of $331.23 and a 52-week-low of $233.71. Moreover, at the end of the last trading period, the closing price was at $276.68.

    Deutsche Bank initiated coverage on Repligen Corp (NASDAQ:RGEN) with a Hold rating. The price target for Repligen is set to $180.00. In the third quarter, Repligen showed an EPS of $0.77, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $274.09 and a 52-week-low of $137.21. Repligen closed at $177.99 at the end of the last trading period.

    With a Buy rating, Deutsche Bank initiated coverage on Bio-Techne Corp (NASDAQ:TECH). The price target seems to have been set at $100.00 for Bio-Techne. Bio-Techne earned $0.45 in the first quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $130.74 and a 52-week-low of $68.00. At the end of the last trading period, Bio-Techne closed at $86.98.

    With a Buy rating, Deutsche Bank initiated coverage on Thermo Fisher Scientific Inc (NYSE:TMO). The price target seems to have been set at $620.00 for Thermo Fisher Scientific. In the third quarter, Thermo Fisher Scientific showed an EPS of $5.08, compared to $5.77 from the year-ago quarter. The stock has a 52-week-high of $672.34 and a 52-week-low of $475.77. At the end of the last trading period, Thermo Fisher Scientific closed at $571.38.

    Deutsche Bank initiated coverage on 10x Genomics Inc (NASDAQ:TXG) with a Buy rating. The price target for 10x Genomics is set to $50.00. 10x Genomics earned $0.37 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $154.10 and a 52-week-low of $23.81. 10x Genomics closed at $35.21 at the end of the last trading period.

    With a Hold rating, Deutsche Bank initiated coverage on Waters Corp (NYSE:WAT). The price target seems to have been set at $350.00 for Waters. Waters earned $2.64 in the third quarter, compared to $2.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $375.24 and a 52-week-low of $265.61. Waters closed at $344.62 at the end of the last trading period.

    Deutsche Bank initiated coverage on West Pharmaceutical Services Inc (NYSE:WST) with a Hold rating. The price target for West Pharmaceutical Servs is set to $250.00. West Pharmaceutical Servs earned $2.03 in the third quarter, compared to $2.06 in the year-ago quarter. The stock has a 52-week-high of $475.00 and a 52-week-low of $206.19. At the end of the last trading period, West Pharmaceutical Servs closed at $251.90.

    Stifel initiated coverage on Pliant Therapeutics Inc (NASDAQ:PLRX) with a Buy rating. The price target for Pliant Therapeutics is set to $33.00. For the third quarter, Pliant Therapeutics had an EPS of $0.65, compared to year-ago quarter EPS of $0.75. The stock has a 52-week-high of $26.25 and a 52-week-low of $3.96. At the end of the last trading period, Pliant Therapeutics closed at $19.06.

    Stifel initiated coverage on Travere Therapeutics Inc (NASDAQ:TVTX) with a Hold rating. The price target for Travere Therapeutics is set to $22.00. For the third quarter, Travere Therapeutics had an EPS of $0.76, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $31.65 and a 52-week-low of $18.39. Travere Therapeutics closed at $18.93 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Clean Energy Fuels Corp (NASDAQ:CLNE). The price target seems to have been set at $12.00 for Clean Energy Fuels. For the third quarter, Clean Energy Fuels had an EPS of $0.06, compared to year-ago quarter EPS of $0.01. The current stock performance of Clean Energy Fuels shows a 52-week-high of $8.65 and a 52-week-low of $4.02. Moreover, at the end of the last trading period, the closing price was at $5.79.

    With a Buy rating, UBS initiated coverage on Plug Power Inc (NASDAQ:PLUG). The price target seems to have been set at $26.00 for Plug Power. In the third quarter, Plug Power showed an EPS of $0.30, compared to $0.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.62 and a 52-week-low of $12.70. Plug Power closed at $14.11 at the end of the last trading period.

    UBS initiated coverage on Bloom Energy Corp (NYSE:BE) with a Buy rating. The price target for Bloom Energy is set to $35.00. In the third quarter, Bloom Energy showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.47 and a 52-week-low of $11.47. Bloom Energy closed at $21.96 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Bunge Ltd (NYSE:BG). The price target seems to have been set at $133.00 for Bunge. For the third quarter, Bunge had an EPS of $3.45, compared to year-ago quarter EPS of $3.72. The stock has a 52-week-high of $128.40 and a 52-week-low of $80.41. At the end of the last trading period, Bunge closed at $94.47.

    With a Neutral rating, UBS initiated coverage on Gevo Inc (NASDAQ:GEVO). The price target seems to have been set at $2.25 for Gevo. For the third quarter, Gevo had an EPS of $0.19, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $5.49 and a 52-week-low of $1.73. Gevo closed at $2.00 at the end of the last trading period.

    UBS initiated coverage on FuelCell Energy Inc (NASDAQ:FCEL) with a Neutral rating. The price target for FuelCell Energy is set to $3.85. For the third quarter, FuelCell Energy had an EPS of $0.08, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $7.33 and a 52-week-low of $2.77. FuelCell Energy closed at $3.65 at the end of the last trading period.

    UBS initiated coverage on Vertex Energy Inc (NASDAQ:VTNR) with a Neutral rating. The price target for Vertex Energy is set to $6.90. In the third quarter, Vertex Energy showed an EPS of $0.28, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.10 and a 52-week-low of $3.30. Vertex Energy closed at $6.54 at the end of the last trading period.

    UBS initiated coverage on Montauk Renewables Inc (NASDAQ:MNTK) with a Sell rating. The price target for Montauk Renewables is set to $9.00. In the third quarter, Montauk Renewables showed an EPS of $0.08, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $20.78 and a 52-week-low of $9.10. At the end of the last trading period, Montauk Renewables closed at $12.01.

    UBS initiated coverage on Aemetis Inc (NASDAQ:AMTX) with a Neutral rating. The price target for Aemetis is set to $4.25. For the third quarter, Aemetis had an EPS of $0.46, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $16.97 and a 52-week-low of $3.71. At the end of the last trading period, Aemetis closed at $4.43.

    UBS initiated coverage on Green Plains Inc (NASDAQ:GPRE) with a Buy rating. The price target for Green Plains is set to $45.00. For the third quarter, Green Plains had an EPS of $1.27, compared to year-ago quarter EPS of $1.18. At the moment, the stock has a 52-week-high of $41.25 and a 52-week-low of $26.09. Green Plains closed at $31.25 at the end of the last trading period.

    With a Buy rating, UBS initiated coverage on Archer-Daniels Midland Co (NYSE:ADM). The price target seems to have been set at $115.00 for Archer-Daniels Midland. In the third quarter, Archer-Daniels Midland showed an EPS of $1.86, compared to $0.97 from the year-ago quarter. The current stock performance of Archer-Daniels Midland shows a 52-week-high of $98.88 and a 52-week-low of $63.04. Moreover, at the end of the last trading period, the closing price was at $93.23.

    With a Buy rating, Needham initiated coverage on BellRing Brands Inc (NYSE:BRBR). The price target seems to have been set at $32.00 for BellRing Brands. BellRing Brands earned $0.31 in the fourth quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $28.95 and a 52-week-low of $20.20. At the end of the last trading period, BellRing Brands closed at $25.12.

    With a Buy rating, Needham initiated coverage on The Simply Good Foods Co (NASDAQ:SMPL). The price target seems to have been set at $42.00 for Simply Good Foods. In the fourth quarter, Simply Good Foods showed an EPS of $0.36, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.77 and a 52-week-low of $29.21. Simply Good Foods closed at $37.79 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ABCM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCM
    $ACRS
    $ADM
    $AGRO

    CompanyDatePrice TargetRatingAnalyst
    Waters Corporation
    $WAT
    2/10/2026$360.00In-line
    Evercore ISI
    Waters Corporation
    $WAT
    2/10/2026$425.00Buy
    Citigroup
    Waters Corporation
    $WAT
    2/10/2026$400.00Overweight
    Barclays
    AutoZone Inc.
    $AZO
    2/9/2026$3900.00Outperform → Neutral
    Robert W. Baird
    Green Plains Inc.
    $GPRE
    2/9/2026$17.00Equal-Weight → Overweight
    Stephens
    Bloom Energy Corporation
    $BE
    2/6/2026$105.00 → $160.00Hold
    TD Cowen
    Healthpeak Properties Inc.
    $DOC
    2/5/2026Buy → Hold
    Argus
    Broadridge Financial Solutions Inc.
    $BR
    2/4/2026$228.00Neutral → Buy
    DA Davidson
    More analyst ratings

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mcatee David R Ii bought $486,720 worth of shares (7,500 units at $64.90) (SEC Form 4)

    4 - Archer-Daniels-Midland Co (0000007084) (Issuer)

    2/9/26 5:27:53 PM ET
    $ADM
    Packaged Foods
    Consumer Staples

    EVP & CIO Boitano David M bought $344,400 worth of shares (10,000 units at $34.44), increasing direct ownership by 64% to 25,626 units (SEC Form 4)

    4 - LTC PROPERTIES INC (0000887905) (Issuer)

    1/2/26 9:39:02 PM ET
    $LTC
    Real Estate Investment Trusts
    Real Estate

    Director George Michael A bought $492,729 worth of shares (145 units at $3,398.13), increasing direct ownership by 34% to 566 units (SEC Form 4)

    4 - AUTOZONE INC (0000866787) (Issuer)

    12/22/25 5:06:23 PM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    $ABCM
    $ACRS
    $ADM
    $AGRO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Caesars Entertainment Inc.

    SCHEDULE 13G/A - Caesars Entertainment, Inc. (0001590895) (Subject)

    2/12/26 10:25:43 AM ET
    $CZR
    Hotels/Resorts
    Consumer Discretionary

    SEC Form 6-K filed by Fortis Inc.

    6-K - Fortis Inc. (0001666175) (Filer)

    2/12/26 7:22:40 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    West Pharmaceutical Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - WEST PHARMACEUTICAL SERVICES INC (0000105770) (Filer)

    2/12/26 7:21:40 AM ET
    $WST
    Medical/Dental Instruments
    Health Care

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI resumed coverage on Waters with a new price target

    Evercore ISI resumed coverage of Waters with a rating of In-line and set a new price target of $360.00

    2/10/26 8:10:12 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Barclays resumed coverage on Waters with a new price target

    Barclays resumed coverage of Waters with a rating of Overweight and set a new price target of $400.00

    2/10/26 8:03:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Citigroup resumed coverage on Waters with a new price target

    Citigroup resumed coverage of Waters with a rating of Buy and set a new price target of $425.00

    2/10/26 8:03:00 AM ET
    $WAT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KITCHENAID INTRODUCES ITS 2026 COLOUR OF THE YEAR: SPEARMINT

    Featuring a sand texture finish, this mint-green hue encourages calm and revitalizing energy amidst the chaos. TORONTO, Feb. 12, 2026 /CNW/ - Today, KitchenAid unveils its 2026 Colour of the Year: Spearmint. Spearmint is a light, uplifting minty-green hue with a tactile, sandy finish that provides a calming, yet revitalizing energy that brightens the world for a step into the fresh side. This year's colour also introduces a new textural finish to the KitchenAid brand Colour of the Year portfolio, Sand. "Research shows that amid global uncertainty, consumers are seeking renewal

    2/12/26 8:01:00 AM ET
    $BBY
    $WHR
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Consumer Electronics/Appliances

    Fortis Inc. Files 2025 Year-End Disclosure Documents

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS), today filed its audited Consolidated Financial Statements, related Management Discussion and Analysis and Form 40-F for the year ended December 31, 2025, as well as its 2025 Annual Information Form, with Canadian securities regulatory authorities. The Corporation also filed its Form 40-F for the year ended December 31, 2025 with the U.S. Securities and Excha

    2/12/26 7:17:46 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    West Reports Fourth-Quarter and Full-Year 2025 Results

    – Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – EXTON, Pa., Feb. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year 2025 Summary (comparisons to prior-year period) Fourth-quarter net sales of $805.0 million increased 7.5%; organic growth was 3.3%.Fourth-quarter diluted earnings per sha

    2/12/26 6:00:00 AM ET
    $WST
    Medical/Dental Instruments
    Health Care

    $ABCM
    $ACRS
    $ADM
    $AGRO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    April 30, 2024 - FDA Roundup: April 30, 2024

    For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/30/24 3:20:20 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 26, 2024 - FDA Roundup: April 26, 2024

    For Immediate Release: April 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/26/24 3:10:22 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Mosconi Patricia Ann

    3 - BROADRIDGE FINANCIAL SOLUTIONS, INC. (0001383312) (Issuer)

    2/12/26 2:35:56 PM ET
    $BR
    Real Estate

    Director Reaume Marty M exercised 1,000 shares at a strike of $51.80 and sold $79,920 worth of shares (1,000 units at $79.92) (SEC Form 4)

    4 - SPS COMMERCE INC (0001092699) (Issuer)

    2/11/26 7:19:21 PM ET
    $SPSC
    Computer Software: Prepackaged Software
    Technology

    Vice President Gryniewicz Craig R exercised 8,748 shares at a strike of $61.26 and sold $1,128,492 worth of shares (8,748 units at $129.00) (SEC Form 4)

    4 - PACCAR INC (0000075362) (Issuer)

    2/11/26 7:01:02 PM ET
    $PCAR
    Motor Vehicles
    Consumer Discretionary

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Financials

    Live finance-specific insights

    View All

    West Reports Fourth-Quarter and Full-Year 2025 Results

    – Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – EXTON, Pa., Feb. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE:WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025. Fourth-Quarter and Full-Year 2025 Summary (comparisons to prior-year period) Fourth-quarter net sales of $805.0 million increased 7.5%; organic growth was 3.3%.Fourth-quarter diluted earnings per sha

    2/12/26 6:00:00 AM ET
    $WST
    Medical/Dental Instruments
    Health Care

    Fortis Inc. Reports Fourth Quarter & Annual 2025 Results

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS), a diversified leader in the North American regulated electric and gas utility industry, released its 2025 fourth quarter and annual financial results.1 Highlights Annual net earnings of $1.7 billion, or $3.40 per common share for 2025Annual adjusted net earnings per common share2 of $3.53, up from $3.28 for 2024Capital expenditures2 of $5.6 billion,

    2/12/26 6:00:00 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    Fortis Inc. Announces Second Quarter Dividends – 2026

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS) has declared the following dividends payable on June 1, 2026 to the Shareholders of Record of the following Shares of the Corporation at the close of business on May 15, 2026: $0.3063 per share on the First Preference Shares, Series "F";$0.3826875 per share on the First Preference Shares, Series "G"; $0.26144 per share on the First

    2/11/26 5:42:27 PM ET
    $FTS
    Electric Utilities: Central
    Utilities

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Leadership Updates

    Live Leadership Updates

    View All

    Martin Marietta Appoints George F. Schoen as Executive Vice President, General Counsel and Corporate Secretary

    RALEIGH, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE:MLM) (Martin Marietta or the Company), a leading national supplier of aggregates and heavy building materials, today announced the appointment of George F. Schoen as Executive Vice President, General Counsel and Corporate Secretary, further strengthening the Company's leadership team as it executes its long-term strategic plan. Mr. Schoen will join the Company in March 2026. Mr. Schoen, who most recently served as Co-Chair of the Global Mergers and Acquisitions Practice at Cravath, Swaine & Moore LLP, is widely recognized as one of the nation's foremost M&A and corporate governance attorneys. He has adv

    2/11/26 4:15:00 PM ET
    $MLM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    The Ritz-Carlton x Kilometre Paris: Iconic Destinations, Reimagined in Handcrafted Travel Pieces

    Drawing inspiration from sun-washed coastlines and resort escapes, the collaboration transforms the spirit of The Ritz-Carlton's most iconic resorts into travel pieces designed to be carried, collected, and remembered. BETHESDA, Md., Feb. 11, 2026 /PRNewswire/ -- Guided by a shared passion for travel and a deep sense of place, The Ritz-Carlton announces a new collaboration with Kilometre Paris, the luxury accessories brand renowned for its hand-embroidered, destination-driven designs. The limited-edition capsule translates four iconic coastal resorts – The Ritz-Carlton, Laguna Niguel, The Ritz-Carlton Bacara, Santa Barbara, The Ritz-Carlton, Amelia Island, and The Ritz-Carlton Key Biscayne,

    2/11/26 11:30:00 AM ET
    $MAR
    Hotels/Resorts
    Consumer Discretionary

    RingCentral Set to Join S&P SmallCap 600

    NEW YORK, Feb. 9, 2026 /PRNewswire/ -- RingCentral Inc. (NYSE:RNG) will replace Hillenbrand Inc. (NYSE:HI) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 12. Lone Star Funds is acquiring Hillenbrand in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Feb 12, 2026 S&P SmallCap 600 Addition RingCentral RNG Information Technology Feb 12, 2026 S&P SmallCap 600 Deletion Hillenbrand HI Industrials ABOUT S&P DOW JONES INDICES S&P Dow Jones Indices is the large

    2/9/26 6:08:00 PM ET
    $HI
    $RNG
    $SPGI
    Miscellaneous manufacturing industries
    Consumer Discretionary
    EDP Services
    Technology

    $ABCM
    $ACRS
    $ADM
    $AGRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Healthcare Realty Trust Incorporated

    SC 13D/A - Healthcare Realty Trust Inc (0001360604) (Subject)

    12/9/24 7:38:49 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by CompoSecure Inc.

    SC 13D/A - CompoSecure, Inc. (0001823144) (Subject)

    11/29/24 5:29:17 PM ET
    $CMPO
    Finance: Consumer Services
    Finance